ArQule Announces Collaboration With NIH For Clinical Development Of ARQ 092 In Proteus Syndrome

By: via Benzinga
ArQule, Inc. (NASDAQ: ARQL) today announced an agreement with the National Human Genome Research Institute (NHGRI) of the National ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.